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Introduction {#s1}
============

Diabetes is becoming a global public health threat, largely due to an increase in type 2 diabetes. The prevalence among adults is expected to rise from 371 million in 2012 to 552 million by the year 2030 [@pone.0102926-Whiting1], [@pone.0102926-Guariguata1]. With the rapid economic growth, increase in life expectancy, and a shift towards a higher calorie diet and sedentary lifestyle, the prevalence of diabetes in China has increased over the past few decades from 2.5% in 1994 to 9.7% in 2008 [@pone.0102926-Pan1], [@pone.0102926-Yang1]. As a result, China now has the largest number of diabetics in the world, with estimates of 92.4 million diabetic adults and an additional 148.2 million adults with prediabetes in 2007--2008 [@pone.0102926-Yang1]. It should be noted that the American Diabetes Association recommends screening adults with prediabetes every year, and those at risk for diabetes every three years [@pone.0102926-American1]. However, to date, the prevalence and trends of the diabetes epidemic in high-risk subjects has not been well examined.

In an effort to describe the prevalence and trends of prediabetes and diabetes among high-risk Chinese adults over the past decade, this study examined oral glucose tolerance test (OGTT) results from Chinese subjects identified as high-risk through an outpatient diabetes screening project (Shanghai High-risk Diabetic screen project, SHiDS). Screenings were performed in patients from the Shanghai Sixth People's Hospital, which is affiliated with Shanghai Jiao Tong University and provides health services to a local population of more than 100,000 people, most of whom are from the Xuhui, Minhang and Changning districts.

Methods {#s2}
=======

Study design and subjects {#s2a}
-------------------------

The SHiDS project involves screening of individuals with known risk factors for diabetes, such as a family history of diabetes, being overweight or obese, previously identified impaired fasting glucose or impaired glucose tolerance, history of gestational diabetes, polycystic ovary syndrome, hypertension, and dyslipidemia. Previously diagnosed diabetic patients were excluded from the study. A total of 10,043 Chinese subjects over 20 years of age living in Shanghai were screened for diabetes between January 2002 and December 2012 and enrolled in the study. This study was approved by the Institutional Review Board of Shanghai Jiao Tong University Affiliated Sixth People's Hospital in accordance with the principles of the Helsinki Declaration. Written informed consent was obtained from each participant.

Participants arrived at the outpatient clinic at around 7∶30 am after at least 8 h of overnight fasting. All participants were asked to complete a nurse-administered standard questionnaire about age, sex, smoking status (smoking status was collected initially from 2009), and personal and family histories of diabetes, cardiovascular diseases, stroke or hypertension and other diseases. A positive diabetic family history was defined by the subject's recollection of a diabetic diagnosis in a first-degree relative (parent, sibling or child). Body mass index (BMI) values were calculated from the height and weight measurements of each subject. Sedentary blood pressure was averaged from three measurements using a standard mercury sphygmomanometer. Venous blood samples were collected at 0, 30, 60, 120 and 180 min following a standard 75 g-OGTT, and plasma glucose levels were assessed using a glucose oxidase method.

Definition of diabetes {#s2b}
----------------------

Prediabetes was defined as an impaired fasting glucose (IFG) ≥6.1 and \<7.0 mmol/L and 2-hour glucose level \<7.8 mmol/L, and/or and an impaired glucose tolerance (IGT) \<6.1 mmol/L and 2-hour glucose level ≥7.8 and \<11.1 mmol/L. Diabetes was defined as a fasting glucose level ≥7.0 mmol/L and/or a 2-hour glucose level ≥11.1 mmol/L [@pone.0102926-Department1].

Definition of overweight and obese {#s2c}
----------------------------------

The criteria recommended by the Working Group on Obesity in China (WGOC) were used to diagnose patients with a BMI ≥24 kg/m^2^ as overweight and those with a BMI ≥28 kg/m^2^ as obese [@pone.0102926-Zhou1].

Statistical analysis {#s2d}
--------------------

All calculations were weighted to represent the total population of Chinese adults (20 years of age or older) on the basis of Chinese population data from 2010. Descriptive statistics were presented as mean or frequency (percentage). Differences between two groups were compared using the Student's *t*-test for means or the chi-square test for proportions. Subsequent analyses were performed by pooling data into five 2-year periods and one 1-year period (2002--2003, 2004--2005, 2006--2007, 2008--2009, 2010--2011, 2012) to enhance robustness. The prevalences of diabetes and prediabetes were adjusted using a direct standardization method according to the Chinese population structure in 2010 [@pone.0102926-NationalBureauofStatisticsofChinaChinaStatistics1]. The analysis of time trend of study variables was conducted using logistic regression models for categorical variables and linear regression for continuous ones. Also, a logistic regression analysis was used to examine the association of time periods, age, sex, BMI and family history with the risk for diabetes. SPSS version 19.0 (SPSS, Inc., Chicago, IL, USA) was used for data statistical analyses with a designation of *P*\<0.05 (two-tailed) as statistically significant.

Results {#s3}
=======

Patient characteristics {#s3a}
-----------------------

The demographic characteristics of all participants categorized by time period are shown in [Table 1](#pone-0102926-t001){ref-type="table"}. There was no significant difference in the mean age of the participants throughout the 11-year study. Furthermore, there were no significant differences in BMI values or the percentages of overweight and obese individuals. While no changes were detected in fasting and 180 min plasma glucose levels across time, there were significant increases in 30, 60 and 120 min plasma glucose levels in 2012 as compared to the initial 2002--2003 period (9.81 *vs.* 9.61, 11.47 *vs.* 10.74, and 9.92 *vs.* 9.33 mmol/L, respectively; all *Ps*\<0.05). Furthermore, the proportion of people with a family history of diabetes increased significantly from 23.58% during 2002--2003 to 40.07% during 2012 (*P*\<0.05). While there were no differences in the associations of BMI and age between males and females ([Figure 1](#pone-0102926-g001){ref-type="fig"}), there were some sex differences observed. First, the proportion of male participants decreased from 51.37% in the first two years of the study to 43.12% in 2012 (*P*\<0.05) ([Table 1](#pone-0102926-t001){ref-type="table"}). Second, while a significant decrease in mean age from 46.12 to 45.73 years (*P*\<0.05) was observed in females over the same time period ([Table 2](#pone-0102926-t002){ref-type="table"}), there was no significant change in age of males. Third, there was a shift towards younger participants over time, observed as an increase in the proportion of younger patients (20--39 y) from the first two-year time period compared with 2012 (males, 12.18 *vs.* 19.89%; females, 11.13 *vs.* 27.69%, respectively; *Ps*\<0.05) with a concurrent decrease in the proportion of older participants (≥60 y) (males, 38.45 *vs.* 27.96%; females, 36.99 *vs.* 29.27%, respectively; *Ps*\<0.05). Additionally, there was a significant decrease in the proportion of middle-aged female patients (40--59 y; 51.88 *vs.* 43.04%; *P*\<0.05), which was not observed in males ([Tables 2](#pone-0102926-t002){ref-type="table"}, [3](#pone-0102926-t003){ref-type="table"}). The annual percentage changes for subject characteristics from 2002 to 2012 are shown in [Table S1](#pone.0102926.s001){ref-type="supplementary-material"}.
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###### Characteristics of all high-risk Chinese adults from 2002 to 2012.

![](pone.0102926.t001){#pone-0102926-t001-1}

  Characteristics                               2002/2003       2004/2005       2006/2007       2008/2009       2010/2011         2012          *P*       Δ
  ------------------------------------------ --------------- --------------- --------------- --------------- --------------- --------------- --------- --------
  Mean age, y                                 46.41 (0.36)    46.23 (0.34)    46.26 (0.35)    46.15 (0.31)    46.27 (0.31)    46.36 (0.39)     0.061    −0.05
  Age, *n* (%)                                                                                                                                         
  20--39                                       145 (11.66)     178 (12.28)     274 (16.76)     489 (21.38)     505 (23.24)     304 (24.22)    \<0.001   12.56
  40--59                                       630 (50.64)     764 (52.73)     790 (48.32)    1048 (45.82)     975 (44.87)     591 (47.09)    \<0.001   −3.55
  ≥60                                          469 (37.70)     507 (34.99)     571 (34.92)     750 (32.79)     693 (31.89)     360 (28.69)    \<0.001   −9.01
  Sex, *n* (%)                                                                                                                                         
  Male                                         632 (51.37)     695 (48.74)     760 (45.36)    1009 (40.89)     975 (42.44)     558 (43.12)     0.001    −8.25
  Female                                       611 (48.56)     754 (51.26)     875 (54.63)    1278 (59.12)    1198 (57.56)     697 (56.90)     0.001     8.34
  Mean blood pressure, mm Hg                                                                                                                           
  Systolic                                    120.47 (0.50)   122.04 (0.47)   124.21 (0.50)   127.93 (0.36)   128.86 (0.37)   129.19 (0.52)   \<0.001    8.72
  Diastolic                                   79.69 (0.32)    79.22 (0.28)    80.89 (0.28)    83.39 (0.22)    81.43 (0.25)    77.40 (0.31)     0.238    −2.29
  Mean BMI, kg/m^2^                           24.36 (0.10)    24.86 (0.10)    24.67 (0.10)    24.72 (0.08)    24.92 (0.08)    24.69 (0.11)     0.421     0.33
  BMI, *n* (%)                                                                                                                                         
  \<24                                         548 (45.74)     641 (42.8)      678 (40.13)    1063 (45.12)     985 (44.09)     599 (45.25)     0.579    −0.49
  ≥24                                          654 (51.79)     744 (53.61)     752 (47.51)    1194 (53.84)    1174 (55.34)     645 (53.92)     0.579     2.13
  Plasma glucose level during OGTT, mmol/L                                                                                                             
  0 min                                        5.88 (0.04)     6.03 (0.04)     6.26 (0.04)     5.92 (0.03)     6.01 (0.03)     5.95 (0.04)     0.315     0.08
  30 min                                       9.61 (0.07)     9.55 (0.06)    10.22 (0.06)     9.73 (0.05)     9.91 (0.05)     9.81 (0.06)     0.001     0.20
  60 min                                      10.74 (0.10)    10.66 (0.09)    11.72 (0.09)    11.13 (0.07)    11.38 (0.08)    11.47 (0.10)    \<0.001    0.74
  120 min                                      9.33 (0.12)     9.32 (0.10)    10.19 (0.12)     9.81 (0.09)     9.75 (0.09)     9.92 (0.12)    \<0.001    0.58
  180 min                                      6.64 (0.10)     6.69 (0.08)     7.04 (0.10)     6.77 (0.08)     6.69 (0.07)     6.90 (0.10)     0.12      0.26
  Family history, *n* (%)                                                                                                                              
  Yes                                          277 (23.58)     389 (28.15)     420 (25.5)      666 (30.84)     715 (32.26)     498 (40.07)    \<0.001   16.49
  No                                           943 (74.72)    1034 (70.74)    1042 (63.83)    1577 (67.11)    1437 (66.71)     757 (59.93)    \<0.001   −14.79

Abbreviations: BMI, body mass index; OGTT, oral glucose tolerance test.

10.1371/journal.pone.0102926.t002

###### Characteristics of female high-risk Chinese adults from 2002 to 2012.
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  Female characteristics                        2002/2003       2004/2005       2006/2007       2008/2009       2010/2011         2012          *P*       Δ
  ------------------------------------------ --------------- --------------- --------------- --------------- --------------- --------------- --------- --------
  Mean age, y                                 46.12 (0.50)    46.03 (0.47)    45.61 (0.48)    45.44 (0.44)    45.73 (0.45)    45.73 (0.56)     0.012    −0.39
  Age, *n* (%)                                                                                                                                         
  20--39                                       68 (11.13)      88 (11.67)      155 (17.71)     345 (27.00)     338 (28.21)     193 (27.69)    \<0.001   16.56
  40--59                                       317 (51.88)     402 (53.32)     433 (49.49)     536 (41.94)     500 (41.74)     300 (43.04)    \<0.001   −8.84
  ≥60                                          226 (36.99)     264 (35.01)     287 (32.80)     397 (31.06)     360 (30.05)     204 (29.27)    \<0.001   −7.72
  Mean blood pressure, mm Hg                                                                                                                           
  Systolic                                    118.21 (0.74)   120.61 (0.69)   122.83 (0.71)   125.84 (0.51)   126.75 (0.52)   127.01 (0.74)   \<0.001    8.8
  Diastolic                                   77.26 (0.46)    76.92 (0.38)    79.29 (0.39)    81.20 (0.30)    78.98 (0.32)    75.10 (0.43)     0.039    −2.16
  Mean BMI, kg/m^2^                           23.70 (0.16)    24.48 (0.14)    24.19 (0.14)    24.03 (0.11)    24.32 (0.11)    24.15 (0.15)     0.617     0.45
  BMI, *n* (%)                                                                                                                                         
  \<24                                         288 (52.33)     354 (48.18)     395 (45.44)     667 (53.75)     614 (51.21)     379 (54.01)     0.05      1.68
  ≥24                                          299 (44.72)     357 (47.7)      358 (40.82)     590 (44.93)     575 (48.18)     308 (44.70)     0.05     −0.02
  Plasma glucose level during OGTT, mmol/L                                                                                                             
  0 min                                        5.58 (0.05)     5.72 (0.04)     5.97 (0.05)     5.57 (0.04)     5.76 (0.04)     5.66 (0.05)     0.564     0.08
  30 min                                       9.05 (0.09)     9.06 (0.07)     9.69 (0.08)     9.15 (0.06)     9.44 (0.06)     9.31 (0.08)     0.006     0.26
  60 min                                       9.89 (0.14)     9.75 (0.11)    10.71 (0.12)    10.22 (0.10)    10.51 (0.10)    10.66 (0.13)    \<0.001    0.77
  120 min                                      8.86 (0.16)     8.66 (0.13)     9.45 (0.15)     9.08 (0.12)     9.13 (0.11)     9.21 (0.15)     0.008     0.35
  180 min                                      6.58 (0.14)     6.52 (0.11)     6.83 (0.13)     6.59 (0.10)     6.63 (0.09)     6.82 (0.13)     0.059     0.24
  Family history, *n* (%)                                                                                                                              
  Yes                                          159 (27.73)     207 (27.25)     241 (26.39)     384 (29.77)     415 (34.45)     281 (39.33)    \<0.001   11.60
  No                                           443 (70.69)     533 (71.64)     537 (61.95)     873 (68.4)      776 (64.80)     416 (60.67)    \<0.001   −10.02

Abbreviations: BMI, body mass index; OGTT, oral glucose tolerance test.

10.1371/journal.pone.0102926.t003

###### Characteristics of male high-risk Chinese adults from 2002 to 2012.
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  Male characteristics                          2002/2003       2004/2005       2006/2007       2008/2009       2010/2011         2012          *P*       Δ
  ------------------------------------------ --------------- --------------- --------------- --------------- --------------- --------------- --------- --------
  Mean age, y                                 46.71 (0.52)    46.43 (0.50)    46.91 (0.50)    46.88 (0.41)    46.82 (0.42)    47.00 (0.54)     0.871     0.29
  Age, *n* (%)                                                                                                                                         
  20--39                                       77 (12.18)      90 (12.95)      119 (15.66)     144 (14.27)     167 (17.13)     111 (19.89)    \<0.001    7.71
  40--59                                       312 (49.37)     362 (52.09)     357 (46.97)     512 (50.74)     475 (48.72)     291 (52.15)     0.778     2.78
  ≥60                                          243 (38.45)     243 (34.96)     284 (37.37)     353 (34.99)     333 (34.15)     156 (27.96)     0.001    −10.49
  Mean blood pressure, mm Hg                                                                                                                           
  Systolic                                    122.75 (0.67)   123.49 (0.63)   125.60 (0.68)   130.04 (0.51)   130.99 (0.53)   131.40 (0.71)   \<0.001    8.65
  Diastolic                                   82.14 (0.45)    81.55 (0.40)    82.51 (0.41)    85.61 (0.32)    83.90 (0.36)    79.73 (0.42)     0.471    −2.41
  Mean BMI, kg/m^2^                           25.02 (0.14)    25.24 (0.13)    25.15 (0.14)    25.42 (0.11)    25.52 (0.11)    25.24 (0.14)     0.031     0.22
  BMI, *n* (%)                                                                                                                                         
  \<24                                         260 (39.07)     287 (37.35)     283 (34.76)     396 (36.39)     371 (36.89)     220 (36.40)     0.129    −2.67
  ≥24                                          354 (58.93)     387 (59.60)     394 (54.28)     604 (62.85)     599 (62.58)     337 (63.25)     0.129     4.32
  Plasma glucose level during OGTT, mmol/L                                                                                                             
  0 min                                        6.17 (0.06)     6.34 (0.06)     6.55 (0.07)     6.27 (0.05)     6.26 (0.05)     6.25 (0.07)     0.271     0.08
  30 min                                       10.18 (0.1)    10.04 (0.09)    10.75 (0.10)    10.32 (0.07)    10.38 (0.07)    10.31 (0.10)     0.011     0.13
  60 min                                      11.60 (0.14)    11.58 (0.13)    12.74 (0.14)    12.05 (0.11)    12.25 (0.12)    12.30 (0.15)    \<0.001    0.70
  120 min                                      9.81 (0.17)     9.98 (0.16)    10.93 (0.18)    10.55 (0.14)    10.38 (0.14)    10.63 (0.19)    \<0.001    0.82
  180 min                                      6.70 (0.14)     6.86 (0.13)     7.25 (0.15)     6.95 (0.12)     6.76 (0.12)     6.99 (0.16)     0.530     0.29
  Family history, *n* (%)                                                                                                                              
  Yes                                          118 (19.39)     182 (29.06)     179 (24.61)     282 (31.93)     300 (30.04)     217 (40.82)    \<0.001   21.43
  No                                           499 (78.79)     501 (69.82)     505 (65.73)     704 (65.81)     661 (68.65)     341 (59.18)    \<0.001   −19.61

Abbreviations: BMI, body mass index; OGTT, oral glucose tolerance test.

Prevalences of prediabetes and diabetes {#s3b}
---------------------------------------

While the overall prevalence of prediabetes did not change significantly between 2002--2003 and 2012, the overall prevalence of diabetes increased from 27.93 to 34.78% (*P*\<0.05) ([Table 4](#pone-0102926-t004){ref-type="table"}). Compared to the initial two-year time period, there was a significantly increased prevalence of diabetes in males (32.15 *vs.* 42.75%; *P*\<0.05) and females (23.76 *vs.* 26.9%; *P*\<0.05). However, there were sex differences in the age-specific prevalences of diabetes. In young participants (20--39 y), the proportion of diabetes in males and females did not change over time. The prevalence of diabetes in middle-aged (40--59 y) males increased from 37.82 to 47.77% over the course of the study (*P*\<0.05) but remained unchanged in females. The prevalence of diabetes increased significantly in both older (≥60 y) males and females (37.86 *vs.* 49.36%, and 30.53 *vs.* 45.1%, respectively; *P*\<0.05). Furthermore, the increased diabetic prevalence occurred in participants of normal weight, as well as those considered overweight and obese (26.28 *vs.* 29.22% and 37.92 *vs.* 44.96%, respectively; *Ps*\<0.05), and regardless of family history (with family history: 32.49 *vs.* 39.16%, without family history: 32.24 *vs.* 35.93%, *Ps*\<0.05). In contrast, there were no changes over time in the prevalence of prediabetes in any category. The annual percentage changes in diabetes prevalence from 2002 to 2012 are shown in [Table S2](#pone.0102926.s002){ref-type="supplementary-material"}. Furthermore, the proportion of subjects with varying numbers of risk factors, and the corresponding diabetes prevalence over the study time period are shown in [Table S3](#pone.0102926.s003){ref-type="supplementary-material"}, which demonstrates that the prevalence of diabetes is higher in subjects with more risk factors.

10.1371/journal.pone.0102926.t004

###### Overall prevalence of diabetes from 2002 to 2012.
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  Diabetes                             2002/2003    2004/2005     2006/2007    2008/2009     2010/2011       2012       *P*         Δ                                                              
  ----------------------------------- ----------- -------------- ----------- -------------- ----------- -------------- ------ -------------- ------ -------------- ------ -------------- --------- -------
  Standardized                                                                                                                                                                                     
  Overall(adjusted for age and sex)      1244      27.93 (1.27)     1448      28.97 (1.19)     1635      37.74 (1.20)   2287   34.85 (1.00)   2173   33.69 (1.01)   1255   34.78 (1.34)   \<0.001   6.85
  Male(adjusted for age)                  632      32.15 (1.86)      695      36.93 (1.83)      760      44.89 (1.80)   1009   41.99 (1.55)   975    39.85 (1.57)   558    42.75 (2.09)   \<0.001   10.60
  Female(adjusted for age)                611      23.76 (1.72)      753      21.10 (1.49)      875      30.67 (1.56)   1278   27.80 (1.25)   1198   27.60 (1.29)   697    26.90 (1.68)    0.011    3.14
  Crude prevalence                                                                                                                                                                                 
  Overall                                1244      32.50 (1.33)     1448      33.50 (1.24)     1635      42.2 (1.22)    2287   37.90 (1.01)   2173   36.60 (1.03)   1255   37.20 (1.36)    0.018    9.40
  Male                                    632      36.10 (1.91)      695      39.00 (1.85)      760      48.6 (1.81)    1009   45.30 (1.57)   975    43.70 (1.59)   558    45.50 (2.11)   \<0.001   2.00
  Female                                  611      28.60 (1.83)      753      28.40 (1.64)      875      36.7 (1.63)    1278   32.10 (1.31)   1198   30.80 (1.33)   697    30.60 (1.74)    0.555    4.70
  Male                                                                                                                                                                                             
  20--39 y                                77       23.38 (4.82)      90       31.11 (4.88)      119      36.13 (4.40)   144    34.03 (3.95)   167    29.94 (3.54)   111    34.23 (4.50)    0.357    10.85
  40--59 y                                312      37.82 (2.75)      362      42.54 (2.60)      357      49.86 (2.65)   512    47.07 (2.21)   475    45.47 (2.28)   291    47.77 (2.93)    0.020    9.95
  ≥60 y                                   243      37.86 (3.11)      243      36.63 (3.09)      284      52.11 (2.96)   353    47.31 (2.66)   333    48.05 (2.74)   156    49.36 (4.00)    0.001    11.50
  Female                                                                                                                                                                                           
  20--39 y                                68       13.24 (4.11)      88       6.82 (2.69)       155      15.48 (2.91)   345    11.59 (1.72)   338    12.43 (1.79)   193    11.92 (2.33)    0.892    −1.32
  40--59 y                                317      30.60 (2.59)      402      26.87 (2.21)      433      37.64 (2.33)   536    34.33 (2.05)   500    35.60 (2.14)   300    32.67 (2.71)    0.073    2.07
  ≥60 y                                   226      30.53 (3.06)      263      37.88 (2.99)      287      46.69 (2.94)   397    46.85 (2.50)   360    41.39 (2.60)   204    45.10 (3.48)    0.003    14.57
  BMI, kg/m^2^                                                                                                                                                                                     
  \<24                                    548      26.28 (1.88)      641      27.15 (1.76)      678      36.73 (1.85)   1063   29.07 (1.39)   985    29.14 (1.45)   599    29.22 (1.86)    0.037    2.94
  ≥24                                     654      37.92 (1.90)      743      38.71 (1.79)      752      48.8 (1.82)    1194   45.81 (1.44)   1174   42.76 (1.44)   645    44.96 (1.96)   \<0.001   7.04
  Family history                                                                                                                                                                                   
  Yes                                     277      32.49 (2.81)      389      34.45 (2.41)      420      46.90 (2.44)   666    43.99 (1.92)   715    41.12 (1.84)   498    39.16 (2.19)   \<0.001   6.67
  No                                      943      32.24 (1.52)     1033      32.98 (1.46)     1042      41.75 (1.53)   1577   35.57 (1.21)   1437   34.31 (1.25)   757    35.93 (1.74)    0.037    3.69

Abbreviations: BMI, body mass index; SE, standard error of the mean.

Multivariate risk assessment {#s3c}
----------------------------

In the multivariate logistic models, male sex, older age, parental history of diabetes, and overweight/obesity were all significantly associated with an increased prevalence of diabetes ([Table 5](#pone-0102926-t005){ref-type="table"}). After multivariate adjustment, participants were more likely to be diabetic in recent years than in 2002/2003. Compared with 2002/2003, the risk of having diabetes was significantly higher in 2006/2007, 2008/2009, 2010/2011 and 2012 (all *Ps*\<0.05). Results also showed that males were more likely to have diabetes than their female counterparts (*P*\<0.05). Moreover, the prevalence of diabetes was found to be significantly associated with age. The odds ratio for middle-aged participants (40--59 y) was 2.61 (*P*\<0.05) and 3.37 for older participants (≥60 y) (*P*\<0.05) compared to the younger participants (20--39 y). Overweight and obese participants of both sexes were significantly more likely to be diabetic than those of a normal weight (*P*\<0.05). It is also worth noting that individuals with a family history of diabetes were more likely to be diabetic (*P*\<0.05).

10.1371/journal.pone.0102926.t005

###### Multivariate-adjusted odds ratios for diabetes.
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  Variable          Crude relative risk   Multivariate-adjusted relative risk                      
  ---------------- --------------------- ------------------------------------- ------------------- ---------
  Age                                                                                              
  20--39                     1                                                          1          
  40--59             2.64 (2.33--3.00)                  \<0.001                 2.61 (2.29--2.99)   \<0.001
  ≥60                3.20 (2.80--3.65)                  \<0.001                 3.37 (2.94--3.88)   \<0.001
  Sex                                                                                              
  Male               1.67 (1.54--1.81)                  \<0.001                 1.57 (1.44--1.71)   \<0.001
  Female                     1                                                          1          
  BMI, kg/m^2^                                                                                     
  \<24                       1                                                          1          
  ≥24                1.82 (1.68--1.98)                  \<0.001                 1.82 (1.67--1.99)   \<0.001
  Family history                                                                                   
  Yes                1.24 (1.14--1.36)                  \<0.001                 1.29 (1.18--1.42)   \<0.001
  No                         1                                                          1          
  Time period                                                                                      
  2002/2003                  1                                                          1          
  2004/2005          1.05 (0.89--1.23)                   0.575                  1.07 (0.90--1.27)    0.423
  2006/2007          1.52 (1.30--1.77)                  \<0.001                 1.72 (1.46--2.03)   \<0.001
  2008/2009          1.27 (1.10--1.47)                   0.001                  1.45 (1.25--1.70)   \<0.001
  2010/2011          1.20 (1.04--1.39)                   0.015                  1.35 (1.15--1.58)   \<0.001
  2012               1.23 (1.05--1.45)                   0.013                  1.43 (1.20--1.71)   \<0.001

Abbreviations: BMI, body mass index; CI, confidence interval.

Discussion {#s4}
==========

Shanghai has a higher prevalence of diabetes than other cities in China, as it is the largest city and one of the most economically developed areas in China [@pone.0102926-Li1]. This study was performed to assess what changes have occurred since 2002 in the prevalence of diabetes in high-risk individuals living in Shanghai. Although three nationwide population-based surveys were carried out in participants from different communities in China between 2002 and 2012 [@pone.0102926-Yang1], [@pone.0102926-Liu1], [@pone.0102926-Hou1], [@pone.0102926-Xu1], there are few studies on the prevalence and trend of diabetes in high-risk individuals. As these individuals are at risk for developing diabetes, and prediabetes is an important risk factor for the development of overt diabetes and cardiovascular disease [@pone.0102926-Schmidt1], screening programs should target these individuals for maximum therapeutic benefits.

Earlier population-based studies have shown that the prevalence of diabetes increased worldwide from 8.3 to 9.5% in men and from 7.5 to 9.2% in women from 1980 to 2008 [@pone.0102926-Danaei1]. More specifically, diabetic prevalence increased from 2.8 to 4.3% in the UK from 1996 to 2005 [@pone.0102926-Gonzalez1], from 5.2 to 8.8% in Canada from 1995 to 2005 [@pone.0102926-Lipscombe1], from 2.54 to 12.1% in men and from 2.66 to 11.0% in women in China from 2002 to 2010 [@pone.0102926-Liu1], [@pone.0102926-Xu1], and from 5.7 to 8.6% in men and from 5.9 to 8.0% in women in Taiwan from 2000 to 2007 [@pone.0102926-Lin1]. Another study also showed an upward trend in the prevalence of diabetes in China in high-risk subjects between 1995 and 2003, which was much higher than in community-based subjects throughout the survey [@pone.0102926-Wong1].

This study showed an overall increased prevalence of hyperglycemia (diabetes and prediabetes), from 56.14 to 64.37%, in high-risk subjects over the time period. However, this increase was driven by the prevalence of diabetes (increased from 27.93% in 2002 to 34.78% in 2012), as there was no change in the prevalence of prediabetes. These results are in contrast to an earlier nationwide survey in 2007--2008 showing a higher prevalence of prediabetes (15.5%) compared to diabetes (9.7%) [@pone.0102926-Yang1]. Therefore, these results suggest that an alternative diabetes prevention strategy should be used for high-risk individuals.

The results also showed that the prevalence of diabetes increased at a faster rate in high-risk males compared to females, with a 10.6% increase in males but only a 3.1% increase in females over the eleven-year study. Furthermore, only females older than 60 years of age showed a significant increase in the prevalence of diabetes, with an upward trend observed in middle-aged and older males. These results are in agreement with a study from a Taiwanese population between 2000 and 2007 showing the annual increase in diabetes prevalence rates were largest in the age group ≥60 years, followed by 40--59, and 20--39 age groups, and only a small increase in prevalence of diabetes in females compared to males in the 40--59 y age group [@pone.0102926-Lin1]. The greater increase of diabetes prevalence in males is also consistent with previous community-based studies in Shanghai [@pone.0102926-Li1] and Sweden [@pone.0102926-Jasson1]. As the relationship between BMI and age was similar for males and females, the observed sex difference in diabetes prevalence may result from an increased awareness of risk factors in females, who are then more likely to to engage in healthy behaviors than males [@pone.0102926-Lin1], [@pone.0102926-RedondoSendino1]. Notably, the most prominent sex difference was seen in middle-aged particpants (40--59 y), with a 26.3% increase from 2002 to 2012 in males and only a 6.7% increase in females. As the highest prevalence of diabetes occurs in middle-aged and older males, they represent a population that needs greater attention for the prevention of diabetes.

In the present study we explored the association of selected socio-demographic (age), biological (BMI) and genetic (family history) factors and the prevalence of diabetes in high-risk subjects and show that all three influence the prevalence of diabetes, similar to reports from earlier population-based studies among Chinese [@pone.0102926-Yang1], [@pone.0102926-Xu1]. Furthermore, middle-aged males were found to have a 1.67 times higher risk compared to middle-aged females. The risk to individuals with a family history of diabetes was 1.29 times the risk to those without family history, in contrast to a 3.14-fold increase reported in a previous community-based study [@pone.0102926-Yang1]. These discrepancies likely result from the fact that the participants without a family history recruited in our study were already considered high-risk due to multiple other risk factors.

Conclusion {#s5}
==========

In summary, the results demonstrate a high prevalence of prediabetes and diabetes in individuals with multiple risk factors from Shanghai, China. Moreover, the prevalence of diabetes increased significantly from 2002 to 2012, with males older than 40 years at the highest risk for developing diabetes. The rapid increase in the prevalence of diabetes indicates that screening programs targeting high-risk individuals will become even more important as time goes on, and more individuals are at risk.
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